OCALIVA cpr pell 5 mg bte 30 pce

7680665300016 CH-66530 A05AA04 04.99.0.

Reimbursement limitations:

OCALIVA

Ocaliva est indiqué pour le traitement de la cholangite biliaire primitive (CBP) sans cirrhose ou …

OCALIVA cpr pell 5 mg bte 30 pce
OCALIVA cpr pell 5 mg bte 30 pce
OCALIVA cpr pell 5 mg bte 30 pce
1 / 3
google

Details

Product number
6653001
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
acidum obeticholicum 5 mg, excipiens pro compresso obducto.

Articles (1)

Ocaliva 5 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/11/2022
Patient information leaflet
Français
24/11/2022
Patient information leaflet
Italien
24/11/2022
Professional SmPC
Allemand
24/11/2022
Professional SmPC
Français
24/11/2022
Professional SmPC
Italien
24/11/2022

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)

Authorization holder

Advanz Pharma Specialty Medicine

8048 Zürich

Authorization information

Swissmedic authorization number
66530
Drug name
Ocaliva, Filmtabletten
Galenic form
FILM
ATC Code
A05AA04
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
01/06/2018
Authorization expiration date
19/08/2025
IT number
04.99.0.
Domain
Human medicine
Field of application
Primäre biliäre Cholangitis (PBC)

Packaging details

Description (FR)
OCALIVA cpr pell 5 mg bte 30 pce
Description (DE)
OCALIVA Filmtabl 5 mg Ds 30 Stk
Market launch
01/06/2018
Market withdrawal
19/08/2025
Narcotic (BTM)
No

Other packaging sizes

OCALIVA cpr pell 10 mg bte 30 pce
30 TABL
View